MOLECULAR CHARACTERIZATION OF MUSCARINIC ACH RECEPTORS
MOLECULAR CHARACTERIZATION OF MUSCARINIC ACH RECEPTORS
批准号:
3402166
负责人:
WILLIAM L KLEIN
金额:
$8.27万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-23 至 1988-08-31
关键词:
acetylcholine affinity chromatography autoradiography chemical binding electron microscopy gel electrophoresis genetic library genetic translation histochemistry /cytochemistry hybridomas immunochemistry ligands molecular weight monoclonal antibody neural information processing neurochemistry synapses
中文摘要
这项工作的长期目标是了解信号转导是如何
在中枢神经系统胆碱能突触建立和维持;其重点是
毒扁豆碱酸乙酰胆碱的生化、发育及细胞调控
感受器。这些受体介导了很大比例的中枢胆碱能
信号转导,在许多行为和临床上都有牵连
显著的现象,并显示出广泛的换能器和
监管回应。目前看来,分离最合适的方法是
并开始鉴定受体系统蛋白质并产生受体
M细胞和发育研究中的特异性抗体
生物学。因此,我们选择了以下三个目标:
目的#1--构建M受体特异性单抗文库
抗体。部分纯化(250倍)的牛脑受体将被
用于使用已经测试的多种方法的组合来诱导抗体
因为他们的有效性。结合分析和免疫印迹将用于
检测抗体的特异性。
目的#2--提纯并开始鉴定受体分子。
免疫亲和层析将添加到测试的分离中,基于
亚细胞分级、疏水性、电荷、相对分子质量和
特定的糖基化。二维凝胶、沉淀平衡和N-末端
分析将用于检测纯度。配基的特异性、数量
亚基、结合位点数和总的氨基酸组成
将对纯化的分子进行评估。
目标#3--定位受体作为突触发育的功能,
翻译后修饰和胆碱能刺激。这个
以上获得的单抗将用于定位受体。
亚细胞和超微结构水平的鸟类视网膜神经元。一个
一种新的分离分化神经元和HVEM整体的方法
将使用装载分析。
英文摘要
The long-range goal of this work is to understand how signal transduction
is established and maintained at CNS cholinergic synapses; its focus is on
the biochemistry, development and cellular regulation of muscarinic ACh
receptors. These receptors mediate a large proportion of CNS cholinergic
signaling, have been implicated in many behaviorally and clinically
significant phenomena and show a broad spectrum of transductional and
regulatory responses. At present, it appears most appropriate to isolate
and begin characterizing receptor system proteins and to generate receptor
specific antibodies for studies of muscarinic cell and developmental
biology. The following three aims have therefore been chosen:
AIM #1--To generate a library of muscarinic receptor-specific monoclonal
antibodies. Partially purified (250-fold) bovine brain receptors will be
used for antibody induction using a combination of methods already tested
for their effectiveness. Binding assays and western blots will be used in
testing antibody specificity.
AIM #2--To purify and begin characterization of receptor molecules.
Immunoaffinity chromatography will be added to tested separations based on
subcellular fractionation, hydrophobicity, charge, molecular weight and
specific glycosylation. 2D-Gel, sedimentation equilibrium and N-terminal
analyses will be used in testing purity. The ligand specificity, number of
subunits, number of binding sites, and overall amino acid composition of
the purified molecules will be assessed.
AIM #3--To localize receptors as a function of synaptic development,
post-translational modification, and cholinergic stimulation. The
monoclonal antibodies obtained above will be used to localize receptors on
avian retina neurons at the subcellular and ultrastructural levels. A
novel approach employing isolation of differentiated neurons and HVEM whole
mount analysis will be used.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Physiological role of naturally-occuring amyloid beta oligomers
-
批准号:9759747
-
项目类别:
-
资助金额:$19.29万
-
财政年份:2018
-
负责人:WILLIAM L KLEIN
-
依托单位:
Development of a non-fibrillic amyloid-beta oligomer selective positron emission tomography imaging diagnostic for Alzheimer.
-
批准号:9202960
-
项目类别:
-
资助金额:$22.22万
-
财政年份:2016
-
负责人:WILLIAM L KLEIN
-
依托单位:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
-
批准号:8842908
-
项目类别:
-
资助金额:$18.73万
-
财政年份:2014
-
负责人:WILLIAM L KLEIN
-
依托单位:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
-
批准号:8683797
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2014
-
负责人:WILLIAM L KLEIN
-
依托单位:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
-
批准号:8548221
-
项目类别:
-
资助金额:$18.44万
-
财政年份:2012
-
负责人:WILLIAM L KLEIN
-
依托单位:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
-
批准号:8446087
-
项目类别:
-
资助金额:$24.74万
-
财政年份:2012
-
负责人:WILLIAM L KLEIN
-
依托单位:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
-
批准号:7615522
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2007
-
负责人:WILLIAM L KLEIN
-
依托单位:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
-
批准号:7184209
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2007
-
负责人:WILLIAM L KLEIN
-
依托单位:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
-
批准号:7470605
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2007
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimers Disease pathology
-
批准号:6678227
-
项目类别:
-
资助金额:$33.05万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimer's Disease pathology
-
批准号:7805554
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs)in Alzheimers Disease pathology
-
批准号:6931646
-
项目类别:
-
资助金额:$34.61万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimer's Disease pathology
-
批准号:7467169
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs)in Alzheimers Disease pathology
-
批准号:6795925
-
项目类别:
-
资助金额:$34.62万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimer's Disease pathology
-
批准号:7595791
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
NEUROLOGICAL DEFICITS DUE TO TOXIC A BETA OLIGOMERS
-
批准号:6233462
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2001
-
负责人:WILLIAM L KLEIN
-
依托单位:
NEUROLOGICAL DEFICITS DUE TO TOXIC A BETA OLIGOMERS
-
批准号:6615732
-
项目类别:
-
资助金额:$29.23万
-
财政年份:2001
-
负责人:WILLIAM L KLEIN
-
依托单位:
NEUROLOGICAL DEFICITS DUE TO TOXIC A BETA OLIGOMERS
-
批准号:6532552
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2001
-
负责人:WILLIAM L KLEIN
-
依托单位:
MORPHOGENIC SIGNAL TRANSDUCTION IN NEURONS
-
批准号:2703069
-
项目类别:
-
资助金额:$19.22万
-
财政年份:1996
-
负责人:WILLIAM L KLEIN
-
依托单位:
MORPHOGENIC SIGNAL TRANSDUCTION IN NEURONS
-
批准号:2273680
-
项目类别:
-
资助金额:$18.86万
-
财政年份:1996
-
负责人:WILLIAM L KLEIN
-
依托单位:
海外基金